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Introduction {#sec1}
============

Tuberculosis (TB) is one of the top 10 causes of morbidity and mortality in the human population, responsible for 1.6 million deaths and 10 million new infections every year ([@bib73], [@bib31], [@bib78]). The causative agent of TB, *Mycobacterium tuberculosis* (Mtb), primarily resides within the hostile environment provided by the phagosome of macrophages and can therefore resist stress conditions such as low pH, hypoxia, reactive oxygen species, reactive nitrogen species, and nutrient starvation ([@bib36], [@bib59], [@bib60]). Metabolism within this restricted niche is key to the survival and pathogenesis of Mtb ([@bib9], [@bib25], [@bib29], [@bib70]). Understanding Mtb's metabolism within the macrophage has therefore become an important focus for research, with the aim of identifying vulnerable metabolic pathways that could be targeted with drugs. Carbon metabolism in Mtb has been intensively investigated, and host-derived lipids, cholesterol, and CO~2~ have been identified as essential nutrients for intracellular growth and survival of TB in animal models ([@bib9], [@bib10], [@bib26], [@bib28], [@bib37], [@bib55], [@bib56], [@bib63]). Our ^13^C-flux spectral analysis (^13^C-FSA) approach, applied to the intracellular carbon metabolism of Mtb, also demonstrated that several nonessential amino acids are acquired by Mtb from macrophages, highlighting their availability as potential nitrogen sources within the human host. However, the identity of the primary nitrogen sources for intracellular Mtb remains uncertain. Amino acid acquisition and metabolism is important for the pathogenesis of several intracellular bacterial pathogens, including Mtb ([@bib21], [@bib30], [@bib35], [@bib38], [@bib44]). For example, *Salmonella enterica*, *Serovar typhimurium*, and *Streptococcus pneumoniae* require arginine for intracellular survival and virulence ([@bib21], [@bib44]), demonstrating that this amino acid is a nitrogen source. *Listeria monocytogenes* has been shown to acquire aspartate, alanine, and glutamate from the host macrophages for *de novo* amino acid synthesis ([@bib30]). Isotopologue profiling studies also identified the amino acid serine as a carbon and energy source for the growth and replication of *Legionella pneumophilia* ([@bib27]).

*In vitro*, Mtb can utilize a wide range of carbon sources but was only able to utilize 13 out of 95 tested compounds as nitrogen sources ([@bib50]). These included mainly the following amino acids: alanine, asparagine, aspartate, valine, glutamate, glutamine, ornithine, and serine. [@bib1] recently extended this list to include arginine, isoleucine, and proline, and urea has previously been shown to be utilized as a nitrogen source *in vitro* ([@bib49]). The work by [@bib1] also demonstrated that growth rates and yields are higher when Mtb grows with amino acids, as compared with ammonium as nitrogen sources, and that like carbon sources, Mtb can co-metabolize two amino acids simultaneously *in vitro*. However, a comprehensive study to identify the nitrogen sources for intracellular Mtb growing within the host macrophage has never been performed.

The Mtb genome encodes several transporters for both inorganic and organic nitrogen compounds (e.g., ammonium chloride \[Amt\] and nitrate \[NarK2\]), as well as ATP-binding cassette (ABC) amino acid transporters ([@bib17]). Aspartate and asparagine have been detected in the Mtb phagosome, highlighting these amino acids as potential intracellular nitrogen sources. However, while the gene directing the transport of aspartate (AnsP1) was essential for the synthesis of nitrogen-containing compounds in a murine model of TB, this gene was dispensable for intracellular survival, suggesting that aspartate is not the primary nitrogen donor for Mtb growing within macrophages. Conversely, a study by the same group demonstrated that the asparagine transporter (AnsP2) was required for surviving intra-phagosomal acid stress but was dispensable for *in vivo* survival ([@bib35], [@bib36]). Glutamate dehydrogenase (GDH), the enzyme that catalyzes the production of glutamate from 2-oxoglutarate, is also essential for the intracellular survival of Mtb ([@bib19], [@bib34], [@bib69]). However, GDH is also required for resistance to acidic and nitrosative stress in *Mycobacterium bovis* (BCG); therefore, the role of glutamate as a nitrogen source is uncertain. Mtb auxotrophic mutants of leucine, proline, tryptophan, and glutamine have previously been shown to be severely attenuated *in vivo* ([@bib43], [@bib46], [@bib64]), indicating that biosynthesis of these amino acids is required by Mtb growing in the intracellular environment. Several other auxotrophic mutants (e.g., methionine, isoleucine, or valine) can, however, successfully proliferate in macrophages, indicating that these amino acids can be acquired from the macrophage milieu ([@bib4], [@bib54]). Mutagenesis studies are useful in identifying Mtb genes required for nitrogen uptake or metabolism during intracellular or *in vivo* survival; however, none of these studies have directly measured the uptake and assimilation of nitrogen by intracellular Mtb.

Isotopic tracer studies, combined with direct interpretation of the labeling patterns in metabolites, have emerged as a powerful strategy to study the intracellular metabolism of important pathogens ([@bib14], [@bib27]). We previously used ^13^C isotopomer analysis and developed ^13^C-FSA to identify the intracellular carbon sources for Mtb ([@bib10]). However, this approach was unsuitable for the current study because of the lack of backbone rearrangements in the metabolic network, as compared to carbon, and limited mass isotopomer information from single nitrogen atoms. To overcome these limitations, here we developed ^15^N-FSRA, a computational platform for analysis of the uptake of all potential amino acids as nitrogen sources. Specifically, to counteract the limited measurement information, an array of ^15^N labeling experiments was conducted under equal conditions, which was simultaneously evaluated in an integrative system-based approach. This work showed that Mtb uptakes and co-metabolizes multiple intracellular sources of nitrogen when replicating within its human host macrophage. These results identify amino acid metabolism as a target for TB therapeutics while also providing a systems-based tool that can be applied to study the nitrogen metabolism of other intracellular organisms.

Results {#sec2}
=======

Mtb Co-assimilates Multiple Nitrogen Sources during Intracellular Growth {#sec2.1}
------------------------------------------------------------------------

To measure the uptake and assimilation of nitrogen during the intracellular growth of Mtb, THP-1 human macrophages were infected with Mtb in the presence of a ^15^N tracer---aspartate (Asp), glutamate (Glu), glutamine (Gln), leucine (Leu), alanine (Ala), or glycine (Gly)---for 48 h, the isotopic steady-state labeling period established in our previous work ([@bib10]). Asparagine was not tested, as it had previously been shown to be a nitrogen source for intracellular Mtb ([@bib36]). Proteinogenic amino acids were used for isotopomer analysis because they acquire the labeling pattern of their central metabolic precursors and are abundant and stable ([@bib10]) ([Figure S1](#mmc1){ref-type="supplementary-material"}, I). Using an identical method to that developed by [@bib10], macrophage and Mtb fractions were separated, and ^15^N incorporation into proteinogenic amino acids from infected macrophages and intracellular Mtb was measured using gas chromatography-mass spectrometry (GC-MS). Amino acid pairs of glutamate, glutamine and aspartate, asparagine (Asn) cannot be distinguished using GC-MS due to acid hydrolysis, so the ^15^N enrichments for these amino acid pairs are combined as glutamate/glutamine (Glu/n) and aspartate/asparagine (Asp/n), respectively. Experimental controls of uninfected THP-1 macrophages and *in-vitro*-grown Mtb were cultivated in Roswell Park Memorial Institute (RPMI) containing each of the tracers for 48 h. These experiments established that the ^15^N labeling profile of proteinogenic amino acids from intracellular Mtb was distinct from that of Mtb in RPMI ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}, II). For example, the labeled nitrogen from ^15^N~1~-Leu was incorporated predominantly into Leu when Mtb was tested in RPMI, but it was widely dispersed into other amino acids for Mtb growing intracellularly ([Figure S1](#mmc1){ref-type="supplementary-material"}, IID). Similarly, for Mtb in RPMI, the label from ^15^N~1~-Asp, ^15^N~1~-Glu, and ^15^N~2~-Gln was incorporated into Asp/n and Glu/n. However, during intracellular growth, labeled nitrogen from ^15^N~1~-Asp was incorporated into almost all measured amino acids, including Asp/n and Glu/n ([Figures S1](#mmc1){ref-type="supplementary-material"}, IIA--IIC). The distinct ^15^N labeling profiles of intracellular Mtb versus *in-vitro*-grown Mtb in RPMI demonstrated that there was negligible cross-contamination from extracellular Mtb in these experiments. Moreover, there was no cross-contamination during the separation of the macrophage and the intracellular Mtb, as evidenced by the unique labeling profile of proteinogenic amino acids from these two fractions ([Figures 1](#fig1){ref-type="fig"}A and 1C). The labeling profiles of proteinogenic amino acids from infected and uninfected macrophages were virtually identical, indicating that Mtb infection does not significantly perturb the nitrogen metabolism of macrophages ([Figures 1](#fig1){ref-type="fig"}A and 1B).Figure 1Assimilation Pattern of Different Nitrogen Sources(A--D) Heatmaps are shown for amino acids derived from Mtb-infected macrophages (A), uninfected macrophages (B), intracellular Mtb (C), and *in-vitro*-grown Mtb in rosins minimal media (D). Assimilation patterns are shown for six tracers: ^15^N~1~-Asp, ^15^N~1~-Glu, ^15^N~2~-Gln, ^15^N~1~-Leu, ^15^N~1~-Ala, and ^15^N~1~ Gly. Essential amino acids for macrophages are highlighted in blue. Heatmaps were produced using enrichment (%) of amino acids recorded for each of the individual tracer experiments in [Data S1](#mmc2){ref-type="supplementary-material"}. The maximum and minimum enrichments for each heatmap are described using color keys. Enrichments are shown for the following amino acids: alanine (Ala), m/z 260; glycine (Gly), m/z 246; valine (Val), m/z 288; leucine (Leu), m/z 274; isoleucine (Ile), m/z 274; methionine (Met), m/z 320; serine (Ser), m/z 390; threonine (Thr), m/z 404; proline (Pro), m/z 258; phenylalanine (Phe), m/z 336; aspartate/asparagine (Asp/n), m/z 418; glutamate/glutamine (Glu/n), m/z 432; lysine (Lys), m/z 431; arginine (Arg), m/z 442; and tyrosine (Tyr), m/z 466, measured using GC-MS.

In accordance with expectations, most of the amino acids derived from macrophages remained unlabeled, reflecting their direct uptake from unlabeled nitrogen sources in the tissue culture media rather than from any transamination from the tracer ([Figure 1](#fig1){ref-type="fig"}A). This is not the case for intracellular Mtb. For example, labeled nitrogen from ^15^N~1~-Asp, ^15^N~1~-Glu, or ^15^N~2~-Gln was incorporated predominantly into Asp/n, Glu/n, and isoleucine (Ile) in the macrophage, but labeling was measured in nearly all amino acids derived from intracellular Mtb ([Figures 1](#fig1){ref-type="fig"}A and 1C). These data also reveal potential directions of transamination in Mtb. For example, nitrogen from ^15^N~2~-Gln was assimilated into six amino acids---Asp/n, Glu/n, Ile, Leu, valine (Val), or Ala in infected macrophages ([Figure 1](#fig1){ref-type="fig"}A)---whereas in Mtb, eight additional amino acids were labeled ([Figure 1](#fig1){ref-type="fig"}C). As the label from Gln has already been transaminated into several amino acids in the macrophage, any of those macrophage's amino acids could be the source of the Mtb's labeled nitrogen.

Nitrogen Metabolism Is Compartmentalized when Mtb Is Growing Intracellularly {#sec2.2}
----------------------------------------------------------------------------

Our results demonstrate that nitrogen was assimilated differently, depending on the original amino acid source in intracellular Mtb. We use the term "compartmentalization" to refer to the selective transfer of nitrogen from the tracers to other amino acids ([Figure 1](#fig1){ref-type="fig"}C). For example, nitrogen from ^15^N~1~-Asp, ^15^N~1~-Glu, ^15^N~2~-Gln, and ^15^N~1~-Leu was incorporated into many additional amino acids, but nitrogen from ^15^N~1~-Ala and ^15^N~1~-Gly was incorporated predominantly into only Ala, Gly, and serine (Ser) pools, respectively. The enrichment profiles for amino acids obtained from the tracers were also distinct. For example, more than 50% of ^15^N from ^15^N~1~-Asp was transferred to Glu/n: ^15^N~1~-Glu to six amino acids, ^15^N~2~-Gln to eight amino acids, and ^15^N~1~-Leu to Ile ([Figures 1](#fig1){ref-type="fig"}C and [2](#fig2){ref-type="fig"}A). Also, some amino acids were preferentially labeled by particular tracers. For example, the labeling of tyrosine (Tyr) indicates that the nitrogen is transferred from ^15^N~1~-Glu/^15^N~2~-Gln but not from ^15^N~1~-Asp or any other tracers used. Similarly, nitrogen in arginine (Arg) can be donated by ^15^N~1~-Asp, but not from any other tested amino acid ([Figure 1](#fig1){ref-type="fig"}C). To investigate whether the compartmentalized nitrogen distribution is restricted to intracellular growth of Mtb, we performed similar ^15^N tracer experiments with Mtb grown in Roisin's minimal media, with glycerol and ammonium chloride as the carbon and nitrogen source, respectively, with the addition of ^15^N labeled tracers. As can be seen, the results demonstrated compartmentalized distribution of ^15^N from Asp, Glu, Gln, Leu, Ala, and Gly in to the amino acid pools ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}), extending the finding of [@bib1], who demonstrated the compartmentalized distribution of nitrogen from Gln and Asn during *in vitro* growth of Mtb. It is noteworthy that the promiscuous pattern of distribution of nitrogen from both ^15^N~1~-Ala and ^15^N~1~-Gly *in vitro* is very different from the restricted distribution found for intracellular Mtb ([Figures 1](#fig1){ref-type="fig"}C, [2](#fig2){ref-type="fig"}B, [S3](#mmc1){ref-type="supplementary-material"}E, and S3F). To check whether this promiscuous label distribution in *in-vitro*-grown Mtb was biased by the experimental method, we harvested amino acids from *in-vitro*-grown Mtb using the same method as described for intracellular Mtb. We found no difference in label distribution from ^15^N~1~-Ala and ^15^N~1~-Gly in *in-vitro*-grown Mtb using the two methods, which confirmed that the non-promiscuous pattern of these tracers in intracellular Mtb was not experimentally biased ([Figure S2](#mmc1){ref-type="supplementary-material"}, II). The non-promiscuous pattern for these two tracers in intracellular Mtb suggests that these amino acids are scarce, in comparison to other amino acids such as Gln within the Mtb phagosome, and are therefore incorporated directly into biomass by Mtb, rather than being used as nitrogen donors.Figure 2Nitrogen Assimilation is Compartmentalized in Mtb(A) Distinct enrichment of amino acids from each of the tracers in intracellular Mtb.(B) ^15^N assimilation from the tracers into the amino acids in *in-vitro*-grown Mtb.(C) Comparison of ^15^N enrichment from the tracers ^15^N~1~-Glu and ^15^N~2~-Gln in an infected macrophage.(D) Comparison of ^15^N enrichment from the tracers ^15^N~1~-Glu and ^15^N~2~-Gln in intracellular Mtb.Values are mean ± SEM from 3--4 biological replicates. Statistically significant differences were calculated using Holm-Sidak multiple t tests; **^∗^**p \< 0.001.

Out of all the nitrogen sources tested, nitrogen from ^15^N~2~-Gln was most widely distributed to other amino acids in intracellular Mtb, suggesting that Gln is the principal nitrogen donor for Mtb during intracellular growth ([Figures 1](#fig1){ref-type="fig"}C and [2](#fig2){ref-type="fig"}A). The comparison of enrichment profiles between ^15^N~1~-Glu and ^15^N~2~-Gln demonstrated that both tracers gave similar ^15^N distribution patterns in amino acids derived from an uninfected macrophage and an infected macrophage ([Figures 1](#fig1){ref-type="fig"}A and 1B), but ^15^N~2~-Gln provided significantly higher enrichments than^15^N~1~-Glu for the majority of the intracellular Mtb amino acids ([Figure 1](#fig1){ref-type="fig"}C). Direct comparison of ^15^N~1~-Glu and ^15^N~2~-Gln demonstrated that there were no significant differences in enrichments between ^15^N~1~-Glu and ^15^N~2~-Gln in the macrophage ([Figure 2](#fig2){ref-type="fig"}C). But in the case of intracellular Mtb, using the tracer ^15^N~2~-Gln resulted in significant enrichments for the majority of amino acids ([Figure 2](#fig2){ref-type="fig"}D).

Uptake versus *De Novo* Synthesis of Amino Acids in Intracellular Mtb {#sec2.3}
---------------------------------------------------------------------

To further evaluate the role of each macrophage amino acid pool in the provision of nitrogen to intracellular Mtb, we calculated the nitrogen incorporation ratio (NIR) between ^15^N enrichment of amino acids in intracellular Mtb and the same amino acid in the host macrophage. Amino acids acquired directly from the host that are not subject to any additional synthesis or metabolism will have similar ^15^N enrichment as the macrophage amino acids and an NIR of 1. *De no*vo synthesis or additional metabolic processes, such as transamination reactions, will be revealed by different levels of ^15^N enrichment of amino acids in Mtb, compared with that of macrophage amino acids. [Figures 3](#fig3){ref-type="fig"}A--3G show the ratio of ^15^N enrichment for seven amino acids derived from intracellular Mtb compared with amino acids derived from infected macrophages. Amino acids Val, Ile, and Ala had an NIR of 1 for more than one tracer tested as the source of label, suggesting the uptake of these amino acids is directly from the macrophage by Mtb ([Figures 3](#fig3){ref-type="fig"}D--3F). Also, the NIR was \>1 when ^15^N~2~-Gln was used as the tracer, suggesting the biosynthesis of these amino acids in addition to the uptake. Further clues as to the level of uptake versus biosynthesis can be gleaned from closer inspection of the data. For example, when ^15^N~1~-Asp was used as the label for the Asp/n pool, the NIR was \<1 ([Figure 3](#fig3){ref-type="fig"}A), indicating that any Mtb Asp/n imported from the macrophage was being diluted with nitrogen from a source that was less labeled than the macrophage Asp/n pool. However, when ^15^N~2~-Gln was used as the tracer, the ratio for the Asp/n pools was \>4, indicating that any Mtb Asp/n imported from the macrophage was being diluted with nitrogen from a source that was at least 4× more labeled than Asp/n pools from the macrophage. The same was not true when ^15^N~1~-Glu was the source of the label. The obvious conclusion is that the Asp's nitrogen in Mtb is largely derived from the macrophage Gln. Overall, using the tracer ^15^N~2~-Gln resulted in the highest levels of labeling for the majority of the amino acids analyzed, confirming our previous conclusion that Gln is the predominant nitrogen donor for intracellular Mtb.Figure 3Uptake versus *De Novo* Synthesis of Amino Acids in Intracellular Mtb(A--H) The NIR of ^15^N enrichment (%) in intracellular Mtb to infected macrophages is shown for Asp/n, m/z 418 (A), Glu/n, m/z 432 (B), Leu, m/z 274 (C), Ile, m/z 274 (D), Val, m/z 288 (E), Ala, m/z 260 (F), Gly, m/z 246 (G), and Ser, m/z 390 (H). An NIR of 1 indicates that the particular amino acid in Mtb was acquired directly from the macrophage. NIRs were calculated from the enrichments measured from 3--8 individual macrophage infection experiments using the tracers ^15^N~1~-Asp, ^15^N~1~-Glu, ^15^N~2~-Gln, ^15^N~1~-Leu, ^15^N~1~-Ala, and ^15^N~1~-Gly. Ratios that were not determined for Gly (G) and Ser (H) are indicated by ND, and the asterisk indicates maximum ^15^N detected in Mtb from ^15^N~2~-Gln.

NIR analysis also revealed the exclusivity of nitrogen distribution in the Gly and Ser pools of intracellular Mtb ([Figures 3](#fig3){ref-type="fig"}G and 3H). Nitrogen from Gly is not promiscuous, as the label from ^15^N~1~-Gly remained with the Gly and Ser pools. Therefore, Gly is not a nitrogen donor for Mtb. For Gly, a homologous labeling with ^15^N~1~-Gly gave an NIR less than 1, indicating that Mtb's Gly pool is being diluted by a less labeled nitrogen source, but not any of the tested amino acids, since none of them gave significant levels of incorporation into Gly ([Figure 3](#fig3){ref-type="fig"}G). None of the tracers tested provided nitrogen to Ser, except for Gly. The NIR of Ser was 1 for the label from ^15^N~1~-Gly, indicating the biosynthesis of Ser, in which imported Gly is converted to Ser in intracellular Mtb ([Figure 3](#fig3){ref-type="fig"}H).

Development of ^15^N-FSRA to Probe the Uptake of Nitrogen Sources from the Host by Mtb {#sec2.4}
--------------------------------------------------------------------------------------

Qualitative conclusions about the uptake of nitrogen sources can be drawn from simple labeling patterns generated by ^15^N~1~-Ala and ^15^N~1~-Gly ([Figures S3](#mmc1){ref-type="supplementary-material"}, I and II); however, the [Figure S3](#mmc1){ref-type="supplementary-material"} NIR does not account for the intracellular redistribution of nitrogen. Here, we can use neither the traditional ^13^C Metabolic Flux Analysis (MFA), since we want to infer the uptake, nor our former ^13^C-FSA tool, since we have to take too many possible uptakes into account. We therefore developed ^15^N-FSRA to model the nitrogen source uptake by intracellular Mtb. This approach inputs data from the ^15^N tracer experiments into an *in silico* model of central nitrogen metabolism in Mtb, but without making a prior assumption on the number or combination of potential nitrogen sources. The method calculates the range of potential explanations in terms of nitrogen uptake flux relative to biomass contribution, which is consistent with the available labeling datasets simultaneously. We call this the flux spectral range (FSR). The FSR of an amino acid gives an unbiased possibilistic measure, reflecting the possible nitrogen flows.

A ^15^N metabolic model was constructed for Mtb including nitrogen atom transitions and reaction reversibilities ([Data S2](#mmc3){ref-type="supplementary-material"}; [Figure S4](#mmc1){ref-type="supplementary-material"}). The model was able to analyze the amino acid pairs Glu/Gln and Asp/Asn as separate pools and was solely constrained by the biomass equation taken from our previous work ([@bib9]). The uptake of ^15^N labeled amino acids by Mtb was modeled by using the macrophage-derived amino acid mass isotopomer distributions as potential intracellular nitrogen sources. The measurements of all six tracer experiments were incorporated into the model. From the labeling data measurements, histidine (His), Arg, cysteine (Cys), and tryptophan (Trp) were excluded due to the low levels detected. The relative FSRs (minimum ratio, median, and maximum ratio) of amino acid nitrogen uptake flux to the nitrogen content of each amino acid in biomass were deduced ([Data S3](#mmc4){ref-type="supplementary-material"}). For this analysis, amino acids with minimum/maximum FSR of ∼1 indicated that this amino acid is available in the macrophage and fully incorporated into Mtb's biomass, whereas a minimum/maximum FSR of 0 indicates that the amino acid is unavailable and must be completely synthesized *de novo* by Mtb. A minimum or maximum FSR \>1 indicates that the uptake of the amino acid is greater than the biomass requirements; therefore, this amino acid is a likely nitrogen donor. It should be noted that amino acids with FSRs between 0 and 1 may still be nitrogen donors, but the deficit in their uptake compared to biomass requirement must be made up by *de novo* synthesis with an alternative nitrogen source.

^15^N-FSRA identified 14 amino acids (minimum ratio \> 0) that are available and taken up by intracellular Mtb from the macrophage ([Table 1](#tbl1){ref-type="table"}). Nine amino acids had FSRs between 0 and 1, and the biomass nitrogen requirement was met by *de novo* synthesis. The narrow FSR of 1 for Ala confirmed our previous analysis that this amino acid was taken up by Mtb from the macrophage and incorporated directly into the biomass. The analysis showed that Gln and Val are both used as nitrogen donors for the synthesis of other amino acids with high certainty (minimum FSR \> 1). For Asp and Gly, the minimum FSR was \>0 and the maximum \>1, and they are synthesized *de novo* but could also be taken up by Mtb and used as nitrogen donors. Furthermore, our results revealed that nine amino acids (Asn, Ile, Leu, methionine \[Met\], Lys, Tyr, phenylalanine \[Phe\], proline \[Pro\], and threonine \[Thr\]) are synthetized *de novo* to suffice biomass requirements for growth in varying proportions, as seen from the narrow ratio ranges. The roles of Ser and Glu as nitrogen donors could not be resolved computationally, as the minimum FSR was 0 (not taken up from the macrophage) and maximum FSR \> 1 (taken up in excess).Table 1Flux Spectral Ranges Determined with ^15^N FSRACategoryNitrogen SourceFlux Spectral RangeMinimum RatioMaximum RatioMedian↓Asn0.060.190.13↓Pro0.310.380.34↓Thr0.370.490.43↓Ile0.520.640.55↓Tyr0.570.630.60↓Leu0.580.960.61↓Met0.640.770.68↓Phe0.630.750.69↓Lys0.780.820.81→Ala0.98110/○Glu01.630.020/○Ser03.591.31○Gly0.513.170.67○Asp0.6112.462.11↑Gln1.5011.852.47↑Val1.8213.452.88[^3]

Serine Biosynthesis Is Essential for the Intracellular Survival of Mtb {#sec2.5}
----------------------------------------------------------------------

^15^N-FSRA predicted the minimum FSR of Ser to be 0, indicating that there was no uptake of this amino acid from the macrophage and that its biosynthesis is essential for Mtb's survival inside the host. To test this prediction, we constructed a serine auxotroph of Mtb and tested its survival in macropgaes. Ser is biosynthesized in a multistep reaction using 3-phosphoglyceric acid (PGA) as the precursor produced during glycolysis. Phosphoserine transaminase *ser*C (Rv0884c) catalyzes the addition of nitrogen to the carbon backbone of pyruvate to form Ser ([Figure 4](#fig4){ref-type="fig"}A; [@bib6]). In addition to being a proteinogenic amino acid, Ser provides the nitrogen backbone for the synthesis of Gly and Cys and also replenishes the pyruvate pool in central carbon metabolism ([Figure 4](#fig4){ref-type="fig"}A). Phosphoserine transaminase *ser*C, the enzyme that aminated pyruvate to form Ser, was predicted to be essential for the growth of Mtb *in vitro* ([@bib23]). Here, we successfully generated the Δ*serC* H37Rv Mtb strain. The Δ*serC* strain failed to grow without Ser supplementation, compared to the wild-type (WT) and the complemented strain, Δ*serC*::serC ([Figure 4](#fig4){ref-type="fig"}B), confirming serine auxotrophy. Unlike other nitrogen sources that were promiscuous when tested in *in vitro* ([Figure 1](#fig1){ref-type="fig"}D), Ser was not a widely assimilated *in vitro* nitrogen source; nitrogen from ^15^N~1~-Ser was distributed predominantly to Gly ([Figure 4](#fig4){ref-type="fig"}C). This result demonstrates the distinct nitrogen distribution between Ser and Gly via serine hydroxymethyltransferase *glyA1*, *glyA2* ([Figure 4](#fig4){ref-type="fig"}A) and was in concord with our earlier analyses in [Figures 1](#fig1){ref-type="fig"}C and [3](#fig3){ref-type="fig"}H. Furthermore, Δ*serC* was strongly attenuated for intracellular survival in THP-1 macrophages, as compared with WT H37Rv and the complemented strain ([Figures 4](#fig4){ref-type="fig"}D and 4E). These data validate the ^15^N-FRSA predictions and confirm that serine biosynthesis is essential for the intracellular survival of Mtb.Figure 4Serine Biosynthesis Is Essential for the Intracellular Survival of Mtb(A) Metabolic role of *ser*C in Mtb. *serC* catalyzes the production of serine from pyruvate. Gly, Cys, and pyruvate are synthesized from Ser.(B) Growth of wild-type (WT), Δ*serC* mutant, and complement Δ*ser*C::SERC in 7H9 medium supplemented with 10% oleic acid, albumin, dextrose, and catalase (OADC) tested with and without the addition of Ser. Data are the average of three biological replicates ± SD.(C) Assimilation of ^15^N~1~-SER by WT, Δ*serC*, and Δ*serC*::SERC in Rosin's minimal medium with glycerol and NH~4~Cl. Data are the average of three biological replicates ± SD.(D) Growth of WT, Δ*serC*, and Δ*serC*::SERC in THP-1 macrophages. CFUs (colony forming units) of the three strains were recorded for 0 (before infection), 1, 3, and 7 days post-infection.(E) Fold change in CFUs of the three strains over the period of infection.Data are the average of six independent infection experiments, each with three technical replicates for WT and Δ*serC* and one for infection with four technical replicates for Δ*serC*::SERC ± SD. Statistically significant reduction in CFU counts and fold change in CFUs for Δ*serC* as compared to the WT and complement was calculated using Student's t test. ^∗^p \< 0.05; ^∗∗∗^p \< 0.0005. PPP, pentose phosphate pathway; TCA, tricarboxylic acid cycle; 3P-HPyr, 3-phosphonooxypyruvate; 3P-Ser, 3-Phosphoserine; Cys, cysteine; PGA, 3-phosphoglyceric acid; PYR, pyruvate; PEP, phosphoenolpyruvate; GAP, glyceraldehyde 3phosphate; DHAP, dihydroxyacetone phosphate; G6P, glucose-6-phosphate; F6P, fructose 6-phosphate; FBP, fructose bisphosphate; PG6, phosphogluconolactone; RU5P, riboluse 5-phosphate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate; S7P, sedoheptoluse 7-phsophate; X5P, xylulose 5-phosphate; ACCCOA, AcetylCoA; OAA, oxaloacetic acid; MAL, malate; FUM, fumarate; SUC, succinate; SUCCOA, succinyl CoA; OXG, 2-oxoglutarate; ICIT, isocitrate; CIT, citrate.

Discussion {#sec3}
==========

We and others have shown that Mtb co-metabolizes multiple carbon sources during intracellular growth in the human host cell ([@bib10], [@bib26], [@bib55]). Here, we demonstrate that this is also the case for nitrogen. Using ^15^N isotopomer profiling and ^15^N-FSRA systems-based inference tool, we describe the first nitrogen metabolic phenotype of Mtb inside human macrophages ([Figure 5](#fig5){ref-type="fig"}). With the ^15^N-FSRA tool, we predicted that Mtb has access to most amino acids within the macrophage ([Table 1](#tbl1){ref-type="table"}), and this uptake was insufficient to meet the biomass requirement for most tested amino acids and therefore must be complemented with *de novo* synthesis from nitrogen donors. This analysis identified the amino acids Asp, Glu, Gln, Val, Leu, Ala, and Gly as the intracellular nitrogen sources utilized by Mtb in human macrophages.Figure 5Schematic Representation of Nitrogen Metabolism (Acquisition and Assimilation) in Intracellular MtbMacrophages acquires nitrogen sources Asp (aspartate), Glu (glutamate), Gln (glutamine), Leu (leucine), Ala (alanine), and Gly (glycine) directly from the growth media. Glu/Gln is taken from the host via yet-unidentified transporter. Asp is accessible to intraphagosomal Mtb, which it uptakes from the host macrophages via AnsP1 ([@bib36]). Leu, Ile (isoleucine), and Val (valine) are acquired from the host macrophages via yet-unindentified branched chain amino acid, probably an ABC-type transporter. Ala, Gly, and Ser are possibly acquired via CycA transport system. Gln, Val, and Asp were potential nitrogen donors for cellular protein synthesis, with Gln as the principal nitrogen donor in intracellular Mtb (indicated by asterisk). Nitrogen from Gln was transaminated primarily to Glu and Asp for the synthesis of other amino acids. Ala and Gly are assimilated mainly into Ala, Gly, and Ser pools. Limited transamination of nitrogen from Ala and Gly to other amino acids suggests direct assimilation of these two amino acids for biomass-cell wall synthesis.

Further analysis of the data demonstrated that, like carbon metabolism in Mtb ([@bib22]), nitrogen metabolism is compartmentalized ([Figures 1](#fig1){ref-type="fig"}C and 1D). Our *in vitro* results ([Figure 1](#fig1){ref-type="fig"}D) are consistent with the results of [@bib1], who demonstrated that Mtb does not show a preference for any amino acids as nitrogen sources when grown *in vitro*. However, in this study, we demonstrate that this is clearly not the case for Mtb growing inside macrophages. Instead, the principal nitrogen source for intracellular Mtb appears to be Gln, but there is a clear pattern of compartmentalization of distribution of nitrogen with some sources: Gln is a highly promiscuous nitrogen donor, whereas other amino acids, such as Gly and Ala, have a restrictive pattern of nitrogen distribution. Metabolism has been shown to be compartmentalized in other bacteria with microcompartments, such as carboxysomes and metabolosomes, serving to compartmentalize enzymes involved in particular pathways and to restrict the exposure of toxic intermediates to the rest of the cell ([@bib32]). For example, in *Salmonella enterica*, activity of the metabolosome was required to alleviate acetaldehyde toxicity during ethanolamine catabolism ([@bib13]). In the case of intracellular Mtb, different nitrogen sources might be assimilated using enzymes that are similarly localized. For example, enzymes glutamine synthetase and asparaginase are demonstrated to function extracellularly for the catabolism of Gln and Asn, respectively, in Mtb ([@bib42], [@bib36]) as a strategy to resist acidic stress inside the phagosome.

Earlier studies demonstrated that Asp is an intracellular nitrogen source for Mtb, and the pathways for Asp/n assimilation were recently described ([@bib35], [@bib36]). However, although our results confirm that Asp is indeed a nitrogen source, they also demonstrate that, of the tested amino acids, Gln is the principal source of nitrogen for intracellular Mtb and is the amino acid whose nitrogen is most widely assimilated ([Figure 1](#fig1){ref-type="fig"}C). Gln is the major fuel for a variety of mammalian cells including macrophages ([@bib75]), and THP-1 macrophages have previously been shown to assimilate Gln into Glu ([@bib3], [@bib76], [@bib16]). Our previous study demonstrated that carbon from both Glu and Gln was available to Mtb inside the macrophage ([@bib10]). Here, we additionally show that Gln, and not Glu, is the predominant nitrogen donor for intracellular Mtb. Once in Mtb, Gln can be converted to Glu by glutamate synthase (GltB) ([@bib47]), and the nitrogen is transferred to other amino acids by various transaminases ([Figure 5](#fig5){ref-type="fig"}). Our results are thereby consistent with previous studies that have demonstrated that Glu/n biosynthesis is essential for the intracellular growth and survival of Mtb ([@bib40]; [@bib34], [@bib68], [@bib67]). In addition to being the nitrogen donor for other amino acids, Glu/n is also involved in cell wall synthesis and resisting acid and nitrosative stress ([@bib41], [@bib72], [@bib57]). These studies, together with our results, establish Glu/n as the hub of nitrogen metabolism in intracellular Mtb. Gln was involved in modulating host cellular immune responses ([@bib24]), and Mtb infection increased macrophage's metabolic dependency on Gln ([@bib20]). We found no significant changes in macrophage's ^15^N~2~-Gln assimilation profile upon infection by Mtb ([Figure 1](#fig1){ref-type="fig"}A), but there could be an increase in the pool sizes of Gln and its related pathway intermediates. This leads to an intriguing hypothesis that Mtb may facilitate its own intracellular survival by metabolizing Gln in the host, and targeting Glu/n transport and metabolism therefore represents a promising avenue for the development of anti-TB drugs.

Biosynthesis of branched chain amino acids is also essential for the intracellular survival of Mtb ([@bib4]). Here, we show that the branched chain amino acid Val is acquired directly by intracellular Mtb and is utilized as a nitrogen donor in addition to Gln ([Figure 3](#fig3){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}). Val was not directly tested as a tracer for the ^15^N experiments in the macrophage and intracellular Mtb, but the Val pool was ^15^N labeled from all of the amino acid tracers (except for ^15^N~1~-Ala and ^15^N~1~-Gly), suggesting that nitrogen was shared between Val and other amino acids. A Val auxotroph of Mtb was able to survive in macrophages ([@bib4]); this is consistent with our FSRA predictions that intracellular Mtb acquired Val from the host. Nitrogen from Val is reversibly transaminated to Glu, Ile, and Leu by *ilvE*, the branched chain transaminase that is required for mycobacterial survival during infection in the mice model ([@bib39], [@bib62], [@bib66]). The demonstration by [@bib77] that the biosynthetic genes for branched chain amino acids were downregulated when Mtb was growing intracellularly in macrophages is consistent with our evidence that these amino acids are also available in the phagosome. Our finding that nitrogen from Leu is assimilated by intracellular Mtb is surprising, since a Δ*leuD* auxotroph of Mtb was shown to be severely attenuated for growth and virulence in murine bone-marrow-derived macrophages and in mice, suggesting that Leu was unavailable to Mtb growing within its host ([@bib15], [@bib43], [@bib61]). The ^15^N-FSRA showed that Leu uptake is insufficient for Mtb's biomass requirements, indicating that the uptake must be supplemented by *de novo* synthesis, consistent with the auxotrophic results.

Our previous work showed that the carbon backbone of Ala was acquired from the host and directly incorporated into Mtb's biomass ([@bib10]). Here, we show that Ala was not a nitrogen donor for intracellular Mtb ([Figure 1](#fig1){ref-type="fig"}C; [Table 1](#tbl1){ref-type="table"}). Gly was also a nitrogen source for intracellular Mtb, but its nitrogen was similarly not widely assimilated. Both Ala and Gly are components of the mycobacterial cell wall ([@bib2], [@bib52], [@bib72]), so it seems likely that these amino acids acquired from the host are directly incorporated into cell wall synthesis ([@bib10]). ^15^N-FSRA predicted zero uptake of Ser, suggesting that its biosynthesis may be essential for the intracellular replication of Mtb and thereby a potential drug target. To test this hypothesis, we constructed a Ser auxotroph of Mtb and demonstrated that it is severely attenuated for growth in the macrophage. Our findings validate our systems-based approach and highlight Ser biosynthesis, and particularly the transaminase *ser*C, as a potential drug target.

In addition to biosynthesis, the transport systems of nitrogen sources are potential targets for anti-TB drug development. However, there is only limited knowledge of the amino acid transport systems in Mtb ([@bib18]). The Asp transporter AnsP1 is essential for the virulence of Mtb in murine models ([@bib35]). Although Glu and branched chain amino transport systems are yet to be identified, the *Streptococcus mutans* and *Lactococcus lactis glnQHMP* system is known to transport Glu ([@bib45], [@bib33]), and Mtb encodes GlnQ and GlnP homologs that could function as Glu/n transporters ([@bib17], [@bib12]). The common transporter for Ala, Gly, and Ser, cycA, also remains unstudied ([@bib5], [@bib15], [@bib17]). Further investigations are required to define these amino acid transporters of Mtb.

In summary, we describe the first nitrogen metabolic phenotype of intracellular Mtb and the development and application of a novel computational systems-based tool, ^15^N-FSRA, to investigate nitrogen uptake and assimilation of not only Mtb, but also any intracellular pathogen, in complement with direct isotopic labeling interpretation. In conclusion, we have identified that multiple nitrogen sources are acquired and assimilated by Mtb inside the host macrophages, and Gln is the principal intracellular nitrogen donor. The biosynthetic and transport systems of these identified nitrogen sources---and in particular, phosphoserine transaminase---involved in Ser biosynthesis are a target for the development of innovative anti-TB therapies.

STAR★Methods {#sec4}
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Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial Strains***Mycobacterium tuberculosis* H37Rv[@bib10]N/A*Mycobacterium tuberculosis* Δ*serC* H37RvThis workN/A*Mycobacterium tuberculosis* Δ*serC*::SERCThis workN/A*Escherichia coli* DH5α[@bib9]N/A**Experimental Models: Cell Lines**THP-1 human monocytic cell line[@bib10]ATCC TIB-202**Chemicals, Peptides and Recombinant Proteins**Middle brook7H11 agarSigma-AldrichM0428-500GMiddlebrook 7H9Sigma-AldrichM0178-500GOleic acid-albumin-dextrose-catalase enrichment supplement-500mlBecton Dickenson212351 (4312351)Rosins minimal media[@bib9]N/ALuria-Bertani (LB) mediumSigma-AldrichL3027-250GGlycerolSigma-AldrichG7893-1LTyloxapolSigma-AldrichT8761-50GFetal calf serumSigma-AldrichF9665-500MLRPMI medium 1640Sigma-AldrichR0883^15^N~1~ aspartic acidSigma-Aldrich332135-100MG^15^N~1~ leucineSigma-Aldrich340960-500MG^15^N~1~ glycineSigma-Aldrich299294-250MG^15^N~2~ glutamineSigma-Aldrich490032-250MG^15^N~1~ glutamic acidSigma-Aldrich332143-100MG^15^N~1~ alanineSigma-Aldrich332127-500MGL-glutamineSigma-AldrichG7513-100MLHydrochloric acidSigma-Aldrich258148-500MLPhorbol 12-myristate 13-acetateSigma-AldrichP8139-1MGPhosphate buffer saline (PBS)Sigma-AldrichD8537-500MLNH~4~ClSigma-Aldrich299251-20Gtert-butyldimethyl silyl chloride (TBDMSCl)Sigma-Aldrich00942-10MLGigapack III Plus Packaging ExtractAgilent Technologies200204L-SerineSigma-AldrichS4500Q5 High-Fidelity 2X Master MixNew England BiolabsM0492S^15^N~1~-serineSigma-Aldrich609005-500MG**Software and Algorithms**Isotopomer Network Compartmental Analysis (INCA)[@bib74]N/AMetalign[@bib51]N/A13CFLUX2[@bib71]N/AOmixOmix Vizualization GmbH & Co. KGChemstationAgilent TechnologiesN/AIntegrative Genomics ViewerUniversity of CaliforniaN/ASnap Gene viewerGSL Biotech LLCN/AGraph Pad Prism 8.0GraphPad SoftwareN/AMATLABThe MathWorks, IncN/ANCBI Primer BlastNIHN/A**Other**Plasmid sequencingSource Biosciences, UKN/AWhole genome sequencingMicrobesNG, UKN/A

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and request for resources should be directed to and will be fulfilled by the Lead Contact, Johnjoe McFadden (<j.mcfadden@surrey.ac.uk>). Plasmids and strains generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Sources of *Mycobacterium tuberculosis, E. coli and* cell lines used for this study are reported in the [Key Resources Table](#sec4.1){ref-type="sec"}.

Method Details {#sec4.4}
--------------

### Mycobacterium tuberculosis (Mtb) cultivation {#sec4.4.1}

Mtb, H37Rv was cultivated on Middle brook7H11 agar and Middlebrook 7H9 broth with 5% (v/v) oleic acid-albumin-dextrose-catalase enrichment supplement and 0.5% (v/v) glycerol. Roisins minimal media was prepared with the composition described in [@bib9] and supplemented with 0.5% glycerol (v/v) as the carbon source and 10mM NH~4~Cl as nitrogen source, 0.1% tyloxapol (v/v) at 37°C with agitation (150 rpm).

### THP-1 macrophage cultivation {#sec4.4.2}

The human monocytic THP-1 cell line was grown in RPMI 1640 medium supplemented with 10% heat inactivated fetal calf serum at 37°C, 5% CO~2~ and 95% humidity. For ^15^N labeling experiments, modified RPMI supplemented with 0.2mM L-glutamine was used for testing ^15^N~1~ aspartic acid and ^15^N~1~ glutamic acid.RPMI without L-glutamine was used for testing ^15^N~2~ glutamine (sigma). RPMI-1640 with 200 mM L-glutamine was used for testing ^15^N~1~ leucine, ^15^N~1~ ala and ^15^N~1~ glycine.

### ^15^N isotopic labeling during infection of macrophages with Mtb {#sec4.4.3}

For infection, THP-1 cells and Mtb cultures were prepared as described in [@bib10]. THP-1 cells (3 X 10^7^) were differentiated into macrophages for 3 days using 50 nM Phorbol 12-myristate 13-acetate in a 175 cm^2^ tissue culture flasks. Macrophages were washed with warm PBS supplemented with 0.49 mM Mg^2+^ and 0.68 mM Ca^2+^ (PBS^+^) and 30 mL of RPMI media was added. Mtb was grown in 7H9 broth for a week to an optical density of 1 (1 × 10^8^ colony forming units per ml). Mtb cultures were washed 3 times with PBS and resuspended in RPMI media and added to the macrophages at a multiplicity of infection- 5. Each amino acid tracer except for ^15^N~2~ glutamine was then added to the Mtb-infected macrophages at 3 times the concentration of that unlabelled amino acid present in the RPMI. For ^15^N~2~ glutamine experiment, RPMI without unlabelled glutamine was used, because a large amount of unlabelled glutamine was present in RPMI as compared to other amino acids. To reduce the costs of the ^15^N~2~ glutamine labeling experiment, the only glutamine in this RPMI was the tracer itself, added at 1 mM concentration which previously demonstrated by Tullius et al., 2003 and also confirmed in this study to have no detrimental effect on the macrophages (data not shown). The final concentration of tracers added during infection were- 0.6 mM ^15^N~1~ aspartic acid, 0.53 mM ^15^N~1~ glutamic acid, 0.8 mM ^15^N~1~ leucine, 0.3 mM ^15^N~1~ alanine, 1 mM ^15^N~2~ glutamine and 0.4 mM ^15^N~1~ glycine. Mtb infected macrophages were incubated for 3-4 h at 37°C, 5% CO~2~ and 95% humidity. After incubation, macrophages were washed 3 times with PBS, tracers were added and left for 48 h at 37°C, 5% CO~2~ and 95% humidity. After incubation for 48 h, macrophages were washed with cold PBS and Mtb cultures were harvested from macrophages using differential centrifugation ([@bib10]). Amino acid hydrolysates were prepared from macrophage and Mtb using 6 M hydrochloric acid and incubation at 100°C for 24 h. The validity of the method for labeled amino acid extraction from intracellular Mtb was confirmed by comparing the nitrogen assimilation pattern obtained in RPMI grown labeled Mtb (control) ([Figure S1](#mmc1){ref-type="supplementary-material"}, II). The control was set up by washing Mtb cultures with PBS and resuspending in RPMI for 48 h with equal amounts of ^15^N isotope tracers that was previously used for infection assays. After 48 h, Mtb in RPMI were harvested followed preparation of amino acid hydrolysate.

### *In vitro*^15^N isotopic labeling {#sec4.4.4}

Mtb was grown in Roisins minimal spiked with ^15^N isotope tracers and left for 48 h at 37°C and cultures were agitated at 150 rpm. After 48 h, Mtb cultures were washed with triton, PBS and RIPA buffer. Cultures were harvested and amino acid hydrolysate was prepared by boiling Mtb in 6M hydrochloric acid for 24 h.

### Gas-chromatography mass spectrometry (GC-MS) and ^15^N mass isotopomer analysis {#sec4.4.5}

Amino acid hydrolysates were dried and derivatized using pyridine and tert-butyldimethyl silyl chloride (TBDMSCl) (sigma) ([@bib58], [@bib53]). Amino acids were analyzed using a VF-5ms inert 5% phenyl-methyl column (Agilent Technologies) on a GC-MS system. MS data were extracted using chemstation GC-MS software and were baseline corrected using Metalign ([@bib51]). Mass data were corrected for natural isotope effects using Isotopomer network compartmental analysis (INCA) platform ([@bib74]). Average ^15^N in an amino acid was calculated from the fractional abundance of the mass isotopomer in the entire fragment. For this study measurements \> 1% were considered to be significantly enriched by the ^15^N tracers.

### Nitrogen network model (of Mtb) {#sec4.4.6}

A nitrogen transition model was set up for Mtb using information available in databases (KEGG, BioCyc, Tuberculist) and literature. The network model comprises the amino acid biosynthesis pathways of all 20 proteinogenic amino acids, as well as a simplified nucleotide biosynthesis formulation. Reaction reversibilities and requirements for growth were taken from [@bib9]. For 20 protein-derived amino acids unidirectional uptake reactions were formulated while it was assumed that no backflow of nitrogen from Mtb to the phagosome exists. The mass isotopomers observed in the macrophage were deconvolved into distributions of isotopomer species and modeled by additional reactions ([Figure S4](#mmc1){ref-type="supplementary-material"}). For comparability of the inference results across different nitrogen uptake constellations, flux values were formulated relative to the biomass synthesis rate. In total, the model has 98 independent fluxes, from which 50 are intracellular (40 net, 10 exchange) and 48 nuisance fluxes for modeling the deconvolution of the substrate species. This nitrogen transition template model was then duplicated per dataset to give rise to a sextuple model ([@bib11]), where each sub-model shared flux values, biomass requirements, and growth rate. Eventually, the sextuple model had 338 free fluxes (50 intracellular and 288 nuisance fluxes) that had to be inferred from 264 independent labeling measurements (15 measurement groups for Mtb and the host, respectively ([Data S2](#mmc3){ref-type="supplementary-material"}; [Figure S4](#mmc1){ref-type="supplementary-material"}).

### ^15^N Flux Spectral Range Analysis (^15^N-FSRA) {#sec4.4.7}

^15^N-FSRA borrows the concept of parallel data integration from COMPLETE-MFA ([@bib48]) which, however, was reformulated resigning the knowledge of the experimentally inaccessible specific amino acid uptake rates and amending the traditional least-squares fitting approach by a tailored regularization approach to punish model complexity. In short, a penalty term was added to the weighted least-squares functional$$\underset{\mathbf{v}}{\mathit{\min}}\left\| {\mathbf{y}^{\mathbf{m}\mathbf{e}\mathbf{a}\mathbf{s}} - \mathbf{y}^{\mathbf{s}\mathbf{i}\mathbf{m}}} \right\|_{\Sigma}^{2} + \lambda_{1}\left\| \mathbf{v} \right\|_{1} + \lambda_{2}\left\| \mathbf{v} \right\|_{2}^{2}$$where $\mathbf{v}$ are the (independent) fluxes, $\mathbf{y}^{\mathbf{m}\mathbf{e}\mathbf{a}\mathbf{s}},\mathbf{y}^{\mathbf{s}\mathbf{i}\mathbf{m}}$ the measured/simulated data, $\Sigma$ the measurement covariance matrix, and $\lambda_{\mathbf{i}},\mathbf{i} = 1,2$ regularization parameters punishing non-zero flux values ($\lambda_{1} = 10.0$ and $\lambda_{2} = 0.1$).

A multi-start optimization strategy was applied to safeguard against local minima while solving [Equation (1)](#fd1){ref-type="disp-formula"}. The flux fitting procedure was performed with the high-performance simulator 13CFLUX2 ([@bib71]) using the multifitfluxes module with 1,000 randomly sampled starting points and the NAG C optimization library (Version 6.23, Oxford, UK) with a maximum number of 250 iterations. From the 1,000 runs, those with residuals less than a cut-off of 203.5 were accepted (the overall optimal residual value was 182.01, corresponding to a χ^2^ value \> 99.99%, [Data S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}). This resulted in 800 accepted fits. From these accepted estimated flux distributions, FSRs (minimum, maximum, median) for each flux were derived ([Table 1](#tbl1){ref-type="table"}). Histograms of all FSRs are available in supplemental data file S4.

### Construction of serC (Rv0884c) knockout strain of H37Rv {#sec4.4.8}

The knockout (KO) strain Δ*serC* was constructed using the bacteriophage mediated transduction of wild-type H37Rv ([@bib7]). The strains and plasmid and primers used for this work are listed in [Table S1](#mmc1){ref-type="supplementary-material"}A, B. Briefly, the allelic exchange vector was constructed by cloning upstream and downstream flanking regions of *serC* gene into the cosmid vector pYUB854with res sites flanking the hygromycin resistance (HYG^R^) gene. The recombinant cosmid with the allelic exchange substrates was cloned into the *Pac*I site of the temperature sensitive shuttle phasmid phAEB159 using an *in vitro* λ-packaging reaction (GIGA PackII). The mycobacteriophage containing the recombinant pYUB854 was used for transduction of H37Rv. Bacterial cultures were grown up to exponential phase and washed with pre-warmed 7H9 no tween at 37°C. Phage was added at an m.o.i of 10 and incubated at 37°C for 4 h. After infection, cells were spun and plated onto 7H11 agar plates containing 100 μg ml^-1^ hygromycin and 50 μg ml^-1^ L-serine. Plates were incubated for 3 weeks and single colonies were picked for mutant screening. The knockout strain was confirmed by whole genome sequencing analysis where *serC* gene was deleted in H37Rv (Figure [S6](#mmc1){ref-type="supplementary-material"}A, S6B; [Data S5](#mmc6){ref-type="supplementary-material"}).

### Construction of the complement strain ΔserC::SERC H37Rv {#sec4.4.9}

The complement strain was constructed using the integrating shuttle plasmid pMV361 with *hsp60* promoter *E. coli* origin of replication (oriE), the attP and int genes of mycobacteriophage L5 (for integration in the mycobacterial chromosome) and a kanamycin resistance gene (Kan^r^) ([@bib65]). *serC* was amplified using wild-type H437Rv genomic DNA as the template and primers with *EcoR*I and *Hind*III restriction site ([Table S1](#mmc2){ref-type="supplementary-material"}). The amplified fragment was cloned into pMV361 *EcoR*I and *Hind*III sites downstream of the *hsp60* promoter. The recombinant plasmid was transformed into *E. coli* DH5α competent cells and plated onto LB agar containing 50 μg ml^-1^ kanamycin. Transformants were confirmed by digestion of the pMV361*serC* construct with *EcoR*I and *Hind*III. The construct was electroporated into the KO strain Δ*serC* and plated onto 7H11 agar plates containing 100 μg ml^-1^ hygromycin and 25 μg ml^-1^ kanamycin. Plates were incubated for 3 weeks and single colonies were picked for complement strain screening. Genomic DNA of the complement strain was isolated and the fragment containing *hsp60* promoter and *serC* gene was amplified. The complement strain had a PCR product of size 923 kb, identical to that of the construct pMV361*serC* confirming the complementation of the KO strain Figure S7B.

### Growth of ΔserC and ΔserC::SERC H37Rv strains {#sec4.4.10}

For cultivation in agar plates, strains were grown in 7H11 agar supplemented with OADC. For Δ*serC* L-serine was added to the 7H11 + OADC plates at a concentration of 5mM and hygromycin at 100 μg ml^-1^. For Δ*serC*::SERC H37Rv, kanamycin was added at 25 μg ml^-1^ to the 7H11 + OADC plates. For liquid cultures, strains were grown in 7H9 medium with OADC. To test for auxotrophy, Δ*serC* was grown in 7H9 with and without 5mM L-serine. WT and complement was grown in parallel in 7H9 medium with and without serine for comparison with the mutant.

### Macrophage infections with WT, ΔserC and ΔserC::SERC H37Rv strains {#sec4.4.11}

THP-1 macrophages were cultivated as described in [@bib10] and 5 X 10^5^ cells were seeded for each infection. WT, mutant and complement strains were added to the macrophages at an m.o.i of 0.1 for 4 h. After 4 h macrophages were washed and fresh RPMI medium with 10% FBS was added. Macrophage survivability upon infection with the strains was monitored using crystal violet assays during the period of infection (data not shown). For bacterial survivability test, macrophages were lysed with 0.1% Triton X-100 at specific time points- 0 (inoculum before infection of macrophage), day 1, day 3 and day 7, and plated on 7H11 agar plates with OADC. 7H11 plates for Δ*serC* strain were supplemented with 5mM serine and hygromycin was added at 100 μg ml^-1^, and for Δ*serC*::SERC strain, kanamycin was added at 25 μg ml^-1^. Plates were incubated for 3 weeks at 37°C and colony forming unit ml^-1^ were recorded for the three strains.

### ^15^N~1~-serine isotopic labeling {#sec4.4.12}

Starter cultures of WT, mutant and complement strains were cultivated in 7H9 medium with OADC, 5mM L-serine and respective antibiotics for 4-5 days. For labeling experiments, starter cultures were spun and re-suspended Roisin's minimal medium containing glycerol and ammonium chloride as carbon and nitrogen sources respectively, and with 50 μg ml^-1\ 15^N~1~-serine. Cultures were incubated for 48 h at 37°C. After incubation, cultures were spun and amino acid hydrolysates were prepared as described previously. ^15^N enrichment of amino acids was performed with GC-MS as described previously.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical analyses were performed using Student's t test and significant differences were calculated using Holm Sidak method in graph pad prism 8.0. The details of number and type of replicate measurements used for calculating mean and standard error of the mean (SEM) are included in figure legends. Residual values for FSRA predictions (minimum, maximum, median) were calculated in 13CFLUX2 software and are described in details in the methods section.

Data and Code Availability {#sec4.6}
--------------------------

Data generated in this study are available in the supplemental items
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